Newsletter | June 6, 2023

06.06.23 -- Discover The New Possibilities For Increased Dosing Capabilities Offered By Nanoformed APIs

How Approved Drugs Have Evolved Since The '70s

Drugs have become more lipophilic and complex in structure over time due to the industry’s move away from natural products. Despite this shift, fully synthetic drugs continue to grow in diversity and complexity. Innovative strategies are needed to improve bioavailability of these new drugs.

Embracing GMP Manufacturing To Meet Pharma’s Future

As pharma companies aim to overcome development obstacles, it is essential to implement GMP compliance to ensure quality and safety. Explore how incorporating GMP expertise alongside novel technologies that can enhance the properties of active pharmaceutical ingredients (APIs) and dosage forms holds promise for viable clinical and commercial success.

How Drug Delivery Is Enabling A Clinical Trial For Glioblastoma

Glioblastoma multiforme (GBM) is the most common type of malignant primary brain tumor. It is difficult to treat and has a high risk of recurrence after surgery, placing efficacious treatments in high demand. Discover new possibilities for increased dosing capabilities and diffusion across the brain parenchyma offered by nanoformed APIs.

GMP Manufacturing

Nanoform’s GMP facility utilizes its award-winning Controlled Expansion of Supercritical Solutions (CESS®) technology for the manufacture of API nanoparticles to GMP standards, and all GMP activities are regularly inspected by the national competent authority – the Finnish Medicines Agency (Fimea).

Request Information
An Innovative Nanoparticle Medicine Enabling Company

Driven by a passion for innovation, Nanoform supplies best-in-class nanoforming services to the pharmaceutical industry and works with partners to find ground-breaking solutions that enhance drug effectiveness and targeting. “Small is powerful” exemplifies how nanoforming technology can significantly enhance the properties of drug molecules to benefit patients around the world.

Request Information